The platelet activating factor (PAF) signaling cascade in systemic inflammatory responses

被引:119
作者
Yost, Christian C. [1 ,2 ]
Weyrich, Andrew S. [1 ,3 ]
Zimmerman, Guy A. [1 ,3 ]
机构
[1] Univ Utah, Eccles Inst Human Genet, Salt Lake City, UT 84112 USA
[2] Univ Utah, Dept Pediat, Salt Lake City, UT 84112 USA
[3] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA
关键词
Platelet-activating factor; Sepsis; Anaphylaxis; Inflammation; Lipid mediators; FACTOR RECEPTOR ANTAGONIST; RESPIRATORY-DISTRESS-SYNDROME; MULTIPLE ORGAN FAILURE; ACUTE LUNG INJURY; PHASE-II TRIAL; NF-KAPPA-B; FACTOR-ACETYLHYDROLASE; SEVERE SEPSIS; DOUBLE-BLIND; CLINICAL-TRIAL;
D O I
10.1016/j.biochi.2010.02.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The platelet-activating factor (PAF) signaling cascade evolved as a component of the repertoire of innate host defenses, but is also an effector pathway in inflammatory and thrombotic diseases. This review focuses on the PAF signaling cascade in systemic inflammatory responses and, specifically, explores its activities in experimental and clinical sepsis and anaphylaxis in the context of the basic biochemistry and biology of signaling via this lipid mediator system. (C) 2010 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:692 / 697
页数:6
相关论文
共 50 条
  • [31] THE ROLE OF PLATELET-ACTIVATING-FACTOR (PAF) IN INTERSTITIAL PULMONARY-DISEASE
    MARTIN, T
    LOSA, JE
    GARCIASALGADO, MJ
    PEREZARELLANO, JL
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY & CLINICAL IMMUNOLOGY, 1994, 4 (03) : 149 - 157
  • [32] The actions, detection and synthesis of platelet-activating factor (PAF) in mammalian pregnancy
    Liu Yutang
    Sui Shuqin
    Sun Zhongwu
    Bi Bing
    Xu Cuiqing
    Journal of Forestry Research, 1998, 9 (4) : 283 - 287
  • [33] The actions,detection and synthesis of platelet-activating factor (PAF) in mammalian pregnancy
    刘玉堂
    隋淑芹
    孙中武
    毕冰
    许翠清
    JournalofForestryResearch, 1998, (04) : 283 - 287
  • [34] LIPID INHIBITORS OF PLATELET-ACTIVATING-FACTOR (PAF) IN NORMAL HUMAN PLASMA
    WOODARD, DS
    OSTROM, KK
    MCMANUS, LM
    JOURNAL OF LIPID MEDIATORS AND CELL SIGNALLING, 1995, 12 (01): : 11 - 28
  • [35] PLATELET-ACTIVATING-FACTOR (PAF) AND THE DEVELOPMENT OF CHRONIC SUBDURAL-HEMATOMA
    HIRASIMA, Y
    ENDO, S
    KATO, R
    OHMORI, T
    NAGAHORI, T
    NISHIJIMA, M
    KARASAWA, K
    NOJIMA, S
    TAKAKU, A
    ACTA NEUROCHIRURGICA, 1994, 129 (1-2) : 20 - 25
  • [36] Platelet-activating factor and cardiac diseases: Therapeutic potential for PAF inhibitors
    Feuerstein, G
    Rabinovici, R
    Leor, J
    Winkler, JD
    Vonhof, S
    JOURNAL OF LIPID MEDIATORS AND CELL SIGNALLING, 1997, 15 (03): : 255 - 284
  • [37] EFFECT OF PLATELET-ACTIVATING FACTOR (PAF) AND SYNTHETIC ANALOGS ON FIBRINOLYSIS IN RATS
    HOFMANN, B
    MEISGEIER, U
    GREINER, J
    KERTSCHER, HP
    OSTERMANN, G
    FIBRINOLYSIS, 1990, 4 (04) : 247 - 252
  • [38] Effect of platelet activating factor (PAF) on pulmonary circulation in isolated rabbit lung
    Comellas, A
    Tristano, S
    Pesce, L
    Friedman, E
    Marcano, H
    de León, RS
    JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY, 1999, 55 (01) : 1 - 6
  • [39] Platelet-activating factor (PAF)-like oxidized phospholipids: Relevance to atherosclerosis
    Tokumura, A
    Sumida, T
    Toujima, M
    Kogure, K
    Fukuzawa, K
    BIOFACTORS, 2000, 13 (1-4) : 29 - 33
  • [40] BIMODAL EFFECT OF PLATELET-ACTIVATING-FACTOR (PAF) ON AIRWAYS RESPONSIVENESS IS THE RABBIT
    NIEMINEN, MM
    HENSON, PM
    IRVIN, CG
    EXPERIMENTAL LUNG RESEARCH, 1994, 20 (06) : 559 - 577